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Apoptosis of human tongue squamous cell 
carcinoma cell (CAL-27) induced by Lactobacillus 
sp. A-2 metabolites
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Objective: To study the effect of Lactobacillus sp. A-2 metabolites on viability of CAL-27 cells and apoptosis in CAL-27 cells. Methods: Lactobacillus sp. A-2  metabolites 1 and 
2 (LM1 and LM2) were obtained by culturing Lactobacillus sp. A-2 in reconstituted whey 
medium and whey-inulin medium; the cultured CAL-27 cells were treated with different 
concentrations of LM1 and LM2 (0, 3, 6, 12, 24, 48 mg/mL) and assayed by methyl 
thiazolyltetrazolium (MTT) method; morphological changes of apoptotic cell were observed 
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method (FCM) and agarose gel electrophoresis were used to detect the apoptosis of CAL-
27 cells treated with LM1 and LM2. Results: The different concentrations of LM1 and LM2 
could restrain the growth of CAL-27 cells, and in a dose-dependent manner; the apoptosis 
of CAL-27 cells was obviously induced and was time-dependent. Conclusions: Viability 
of CAL-27 cells was inhibited by Lactobacillus sp. A-2 metabolites; Lactobacillus sp. A-2 
metabolites could induce CAL-27 cells apoptosis; study on the bioactive compounds in the 
Lactobacillus sp. A-2 metabolites and their molecular mechanism is in progress.
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are squamous cell carcinomas. Carcinoma of 
tongue represents 25% to 50% of all cases of 
oral squamous cell carcinoma, with the lateral 
border and the anterior two thirds of the tongue 
being the most commonly affected locations3,8,16. 
An estimated 400,000 new cases of cancer of the 
lip and oral cavity (ICD-10 C00-C08) and pharynx 
(excluding the nasopharynx) were diagnosed across 
the world in 2008 (3% of the total)5.
The etiology of oral cancer includes many 
factors, such as tobacco, alcohol, betel quid and so 
on, while the consumption of fruit and vegetables 
is helpful to reduce the risk of oral cancer17. 
Consumption of fermented milk correlates with a 
reduced risk of numerous cancers12. It has been 
reported that Lactobacillus spp. and its metabolites 
have antimicrobial, antioxidant, anti-caries and 
anti-tumor function7,10,13,15.
In this experiment, we have tried to study the 
effect of Lactobacillus sp. A-2 metabolites, obtained 
by culturing Lactobacillus sp. A-2 in reconstituted 
whey medium and whey-inulin medium, on growth 
and apoptosis of human tongue squamous cell 
carcinoma CAL-27 cell lines so as to understand the 
possible role of Lactobacillus sp. A-2 metabolites 
against cancer and provide experimental basis for 
screening new anti-tumor bioactive agent from 
natural source.
MATERIAL AND METHODS
Strain, cell line and chemicals
Lactobacillus sp. A-2 was obtained from Research 
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Centre of Microecological Engineering Technology, 
Qiqihar Medical University, Heilongjiang province, 
the People’s Republic of China. Cell line CAL-27 
was obtained from Cell Resource Center, IBMS, 
CAMS/PUMC. Cell culture medium DMEM (GIBCO, 
Invitrogen Corporation, New York, USA), fetal 
bovine serum and Acridine orange dye (Shanghai 
Sangon Biological Engineering Technology and 
Service Co., Ltd, Shanghai, China), MTT (Amresco 
Inc. Solon, Ohio, USA), annexin V-FITC/PI double 
staining apoptosis detection kit (Nanjing KGI 
biotechnology Co., Ltd, Nanjing, Jiangsu, China) 
were purchased.
Culture media for Lactobacillus sp. A-2
MRS (DeMan rogosa-sharpe) medium
Soya peptone 10 g, beef powder 10 g, yeast 
extract 5 g, glucose 20 g, Tween 801 mL, 
dipotassium hydrogen phosphate 2 g, sodium 
acetate 5 g, ammonium citrate 2 g, magnesium 
sulfate, 200 mg, manganese sulfate 50 mg, solid 
agar supplemented medium 15 g. Water added to 
make a total of 1 L, pH 6.0-6.5, 121°C, sterilized 
for 15 min.
Reconstituted whey medium
Demineralised whey powder 50 g/L, calcium 
carbonate, 20 g/L, pH 6.0-6.5, 121°C sterilized 
for 15 min.
Whey-inulin medium
Demineralised whey powder 50 g/L, calcium 
carbonate, 20 g/L, Inulin 10 g/L, pH 6.0-6.5, 121°C 
sterilized for 15 min.
Preparation of LM1 and LM2
The strain of Lactobacillus sp. A-2 in MRS was 
cultured for 3 times in a row. The culture was 
centrifuged and washed twice with saline solution 
containing 10 mmol/L CaCl2. The supernatant was 
discarded. Bacterial cells suspension was prepared 
using the above mentioned saline solution. The optical 
density (OD) of the suspension was determined 
at 600 nm with UV/VIS spectrophotometer. The 
bacterial cells were inoculated in reconstituted 
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cell concentration of 1 OD/mL, cultured at 40°C for 
48 h. The culture was centrifuged, and supernatant 
was collected. The supernatant was dried by a 
freeze-drying method. The dried powder obtained 
from whey recovery medium was assigned as 
Lactobacillus sp. A-2 metabolite 1 (LM1), while that 
obtained from whey-inulin medium was assigned 
Lactobacillus sp. A-2 metabolite 2 (LM2). LM1 and 
LM2 were stored at -20°C until use.
Cell culture
Human tongue squamous cell carcinoma CAL-27 
cells were cultured in DMEM containing 10% fetal 
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of 5% CO2. Adherent cells monolayer was grown 
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0.05% trypsin digestion solution.
Assessment of cell viability
In the log phase of cell cycle, the cells were 
collected and seeded in a 96-well plate at a density 
of 1.0×104 cells/mL, each well containing 0.1 mL. 
They were treated with LM1 (0, 3, 6, 12, 24 and 48 
mg/mL), cultured for 72 h, after which cell viability 
was measured using MTT assay. Paclitaxel was used 
for positive control and culture medium for blank. 
MTT was added to each well, incubated for 2 h, 
and the supernatant was discarded. Precipitates 
were dissolved in 150 μL DMSO and oscillated for 
5-10 min to dissolve the crystals. Optical density 
was measured at 570 nm using a plate reader. Cell 
growth inhibition was measured using following 
formula:
Cell growth inhibition rate (%)=(1-value of 
experimental group/value of control group)×100%
MTT assay for LM2 was performed and calculated 
in the similar way.
Assessment of cell morphology
CAL-27 cells in a concentration of 2.2×105 cells/
mL were seeded in a cover slip, placed in a 35 mm 
Petri dish, and cultured for 24 h. Then, 36 mg/mL of 
LM1 and LM2 were added in an experimental group. 
Culture medium was used for blank control and 
cultured for 16 h. Subsequently, cover slips were 
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at 4°C) for 5 minutes, stained with Acridine orange, 
washed with PBS (pH 4.8-6), and immediately 
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In a 35 mm Petri dish, 2 mL of cell suspension 
in a log phase with a density of 1.5×106 cells/mL 
were seeded. Cells were incubated at 37°C in a 
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the media were replaced with fresh media containing 
36 mg/mL of LM1 and LM2, and incubated for 12 
h. The treated cells were washed twice with PBS, 
detached using 0.05% of EDTA-free trypsin solution, 
subjected to be stained by annexin V and propidium 
iodine (PI) following manufacturer’s instructions and 
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DNA gel electrophoresis for apoptotic cells
CAL-27 cells with a density of 3×106 cells/mL 
were seeded in a 35 mm diameter Petri dish and 
cultured for 24 h, and then treated with 36 mg/mL 
of LM1 and LM2 for 0, 12, 18, 24 and 30 h. Cells 
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pH 8.0) at 4°C for 10 minutes. 2 μL RNase A (20 
mg/mL) and 2 mL proteinase K (20 mg/mL) were 
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Figure 1- Effect of LM1 and LM2 on viability of CAL-27 cells. Cells were cultured in DMEM+10% FBS with different 
concentrations of LM1 and LM2 for 72 h. Inhibition rates were determined as described in Material and Methods. Each 
point is mean ± Standard Deviation of three experiments.*p<0.01 compared to control (0 mg/mL)
Figure 2- Morphological change of CAL 27 cells with apoptotic features. CAL-27 cells were treated with LM1 and LM2 for 
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added and incubated at 37°C for 60 min. NaCl-
isopropanolol was added. The mixtures were stored 
at -20°C overnight and centrifuged at 7,200 x g 
for 15 min. The extracted DNA was resuspended. 
DNA gel electrophoresis was performed using 1% 
agarose gel. DNA ladders were photographed under 
UV light.
Statistical analysis
Statistical analysis was performed using SPSS 
18.0 software package. Analysis of variance for 
independent samples between groups was executed 
and the results were expressed as mean ± standard 
deviation (SD) and P<0.05 was considered to be 
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RESULTS
Effect of LM1 and LM2 on the viability of 
CAL-27
CAL-27 cells were used for investigating the 
effect of LM1 and LM2 on the viability of human 
tongue squamous cells CAL-27 by MTT assay 
in vitro. It was shown that 3-48 mg/mL LM1 or 
LM2 inhibited cell growth in a dose-dependent 
manner (Figure 1). The half maximal inhibitory 
concentration (IC50) for LM1 and LM2 was found to 
be 15.1 mg/mL and 10.27 mg/mL respectively. It 
was shown that LM1 and LM2 were able to induce 
cytotoxicity in CAL-27 cells. Nevertheless, no 
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CAL-27 was found between LM1 and LM2 (P>0.05).
Effect of LM1 and LM2 on cell morphology
To evaluate whether the cytotoxic effects 
induced by LM1 and LM2 were caused by apoptosis, 
nuclear morphology was observed using Acridine 
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After being treated with LM1 and LM2 at a 36 mg/
mL concentration for 16 h, cell morphology became 
abnormal with cell nuclear shrinkage, and chromatin 
condensation was induced to occur in the treated 
CAL-27 cells (Figure 2). It was suggested that the 
			!!

!

comparison with control.
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Figure 3- Effect of LM1 and LM2 on apoptosis of CAL-27 cells. A: blank control group; B: CAL-27 cells were treated with 
LM1 for 10 h; C: CAL-27 cells were treated with LM2 for 12 h. After staining with annexin V and PI, the cells were subjected 
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Figure 4- Effect of LM1 and LM2 on DNA fragment in CAL-27. CAL-27 cells were treated with LM1 and LM2 for different 
time periods and then collected. DNA was separated, followed by DNA gel electrophoresis (M, Marker: 2,000 bp, 1,000 bp, 
750 bp, 250 bp, 100 bp)
Apoptosis of human tongue squamous cell carcinoma cell (CAL-27) induced by Lactobacillus sp. A-2 metabolites
Effect of LM1 and LM2 on apoptosis in CAL-
27
To investigate the apoptosis-inducing effects 
of LM1 and LM2, CAL-27 cells treated with a 
concentration of 36 mg/mL LM1 for 10 h and LM2 for 
12 h were analyzed by annexin V and PI staining on 
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3). For LM1, the percentages of early apoptotic 
CAL-27 cells was 12.8%, while the percentages of 
the late cells was 47.3%; for LM2, the percentages 
of early apoptotic CAL-27 cells was 11.22%, while 
the percentages of the late cells was 69.48%.
Effect of LM1 and LM2 on DNA fragment in 
CAL-27
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DNA ladders were detected after CAL-27 cells were 
exposed to 36 mg/mL of LM1 and LM2 for a different 
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LM1 and LM2 were able to induce late apoptosis in 
CAL-27 cells.
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DISCUSSION
Apoptosis refers to programmed cell death. In 
the process of apoptosis, there were changes in 
the morphology of the cells, such as chromatin 
condensation and a reduction in cell volume, 
associated with fragmentation of DNA into 
nucleosomal size fragments of 180-200 bp or 
multiples thereof in many systems, and apoptotic 
bodies were formed1.
Whey proteins and inulin are natural products 
with bioactivities. β-Lactoglobulin (BLG-58%)
and α-lactalbumin (ALA-13%) are major proteins 
in whey. β-Lactoglobulin is the main source of 
sulfur amino acid and has immune modulatory 
effects, while a-lactalbumin forms complexes 
with oleic acid named HAMLET/BAMLET (human/
bovine a-lactalbumin made lethal to tumor cell). 
The protein-liquid complexes selectively induce 
apoptosis in tumor cells14. Meanwhile, whey protein 
also contains a large number of biologically active 
peptides and amino acids which are released through 
degradation of microbial fermentation9,11. Inulin and 
its hydrolyzed products, fructooligosaccharides 
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reducing concentration of serum cholesterol and 
reducing risks of colon cancer and intestinal 
infections2,4,6.
In this study, the source of Lactobacillus sp. A-2 
is yogurt, from which it is separated and screened 
out. It is an anaerobic organism. The strain could 
grow in reconstituted whey medium and whey-inulin 
medium. The metabolites, LM1 and LM2, which 
contain a number of peptides, amino acids, short 
chain fatty acids, lactic acid, butyric acid and certain 
other chemicals, were obtained after incubation 
for 48 h at 40°C. There is much less research on 
prevention of oral cancer using those metabolites.
In this experiment, we used human tongue 
squamous cell carcinoma CAL-27 cell line culture 
model to evaluate the effect of LM1 and LM2 
on cancer cells, which provides theoretical 
and experimental basis for the use of probiotic 
metabolites in prevention and treatment of oral 
cancer. It was demonstrated that both LM1 and LM2 
inhibited the growth of CAL-27 cells and induced 
apoptosis in CAL-27 cells in vitro. The cytotoxic 
effect of LM1 and LM2 on CAL-27 cells is similar. It 
was suggested that inulin had no synergistic effect 
in inhibiting the growth of CAL-27 in whey medium. 
Screening new anti-tumor bioactive agent from LM1 
or LM2 remains to be further studied.
CONCLUSION
Lactobacillus sp. A-2 metabolites in reconstituted 
whey medium and whey-inulin medium have 
a potential role in the inhibition of growth and 
induction of apoptosis of human tongue squamous 
cell carcinoma CAL-27 cells in vitro.
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